{"count": 2, "results": [{"_id": "27781075", "pmid": 27781075, "pmcid": "PMC5066015", "title": "Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo", "journal": "Oxid Med Cell Longev", "authors": ["Yang X", "Ding H", "Qin Z", "Zhang C", "Qi S", "Zhang H", "Yang T", "He Z", "Yang K", "Du E", "Liu C", "Xu Y", "Zhang Z"], "date": "2016-01-01T00:00:00Z", "doi": "10.1155/2016/4156075", "meta_date_publication": "2016", "meta_volume": "2016", "meta_issue": "", "meta_pages": "4156075", "score": 50085.02, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ suppressed @<m>DISEASE_Crystal_Arthropathies</m> @DISEASE_MESH:D000070657 @@@urinary crystal deposit@@@ formation through renal tubular cell protection and antioxidative effects.", "citations": {"NLM": "Yang X, Ding H, Qin Z, Zhang C, Qi S, Zhang H, Yang T, He Z, Yang K, Du E, Liu C, Xu Y, Zhang Z. Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo Oxid Med Cell Longev. 2016;2016():4156075. PMID: 27781075", "BibTeX": "@article{27781075, title={Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo}, author={Yang X and Ding H and Qin Z and Zhang C and Qi S and Zhang H and Yang T and He Z and Yang K and Du E and Liu C and Xu Y and Zhang Z}, journal={Oxid Med Cell Longev}, volume={2016}, pages={4156075}}"}}, {"_id": "30720053", "pmid": 30720053, "pmcid": "PMC6414169", "title": "Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo", "journal": "Int J Mol Med", "authors": ["Yang X", "Yang T", "Li J", "Yang R", "Qi S", "Zhao Y", "Li L", "Li J", "Zhang X", "Yang K", "Xu Y", "Liu C"], "date": "2019-04-01T00:00:00Z", "doi": "10.3892/ijmm.2019.4084", "meta_date_publication": "2019 Apr", "meta_volume": "43", "meta_issue": "4", "meta_pages": "1611-1622", "score": 50062.12, "text_hl": "Therefore, the results of the study suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suppressed urinary @<m>DISEASE_Crystal_Arthropathies</m> @DISEASE_MESH:D000070657 @@@crystal deposit@@@ formation, possibly by mediating the expression of @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ mediators @GENE_SPP1 @GENE_478471 @@@OPN@@@ and MCP-1.", "citations": {"NLM": "Yang X, Yang T, Li J, Yang R, Qi S, Zhao Y, Li L, Li J, Zhang X, Yang K, Xu Y, Liu C. Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo Int J Mol Med. 2019 Apr;43(4):1611-1622. PMID: 30720053", "BibTeX": "@article{30720053, title={Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo}, author={Yang X and Yang T and Li J and Yang R and Qi S and Zhao Y and Li L and Li J and Zhang X and Yang K and Xu Y and Liu C}, journal={Int J Mol Med}, volume={43}, number={4}, pages={1611-1622}}"}}]}